Blood Clot

A Tulane University neurosurgeon is among the first to perform a procedure with Minnetronix Medical’s MindsEye expandable port, a minimally invasive device for surgical treatment of stroke, cancer and other neurological conditions.

Individuals with long COVID may have a higher risk for abnormal blood clotting, especially those who have difficulties with basic exercise for more than 12 weeks after infection, according to a study published in Blood Advances.

According to a meta-analysis of three studies, prolonged TV viewing was associated with elevated risk for venous thromboembolism, independent of traditional risk factors, including age, sex, BMI and physical activity.

Cardiovascular Systems Inc. announced a recall of its embolic protection device due to complaints of filter breakage during retrieval of lower limb blood clots associated with atherectomy procedures in lower limbs.

FDA approved rivaroxaban in tablet form and as an oral suspension to treat and reduce the risk for recurrence of venous thromboembolism among certain populations of children.

Pharmacomechanical catheter-directed thrombolysis using an endovascular catheter was safe and effective in patients with pulmonary embolism, according to interim results of the RESCUE trial presented at VIVA 21.

Use of e-cigarettes that contain nicotine may cause an immediate increase in blood clot formation and deterioration of the expansion and dilation of small blood vessels, researchers reported.

Royal Philips announced the FDA has granted breakthrough device designation for its laser-assisted inferior vena cava filter removal device.

The FDA approved dabigatran etexilate oral pellets for multiple indications.

For this issue, Cardiology Today spoke with Editorial Board Member Jeffrey S. Berger, MD, associate professor of medicine and surgery with appointments in cardiology, hematology and vascular surgery at NYU Grossman School of Medicine and director of the Center for the Prevention of Cardiovascular Disease at NYU Langone Health.